Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 2
1954 2
1955 1
1957 3
1958 3
1959 1
1960 1
1961 1
1964 1
1968 1
1970 1
1972 1
1975 3
1976 3
1977 3
1978 2
1979 2
1980 2
1981 1
1982 3
1983 3
1984 18
1985 5
1986 7
1987 23
1988 17
1989 40
1990 20
1991 19
1992 54
1993 29
1994 65
1995 81
1996 92
1997 94
1998 79
1999 62
2000 89
2001 84
2002 70
2003 74
2004 80
2005 85
2006 91
2007 70
2008 58
2009 64
2010 65
2011 74
2012 75
2013 71
2014 64
2015 67
2016 62
2017 66
2018 63
2019 46
2020 57
2021 57
2022 54
2023 50
2024 60
2025 46

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,354 results

Results by year

Filters applied: . Clear all
Page 1
Multiple endocrine neoplasia type 2: A review.
Mathiesen JS, Effraimidis G, Rossing M, Rasmussen ÅK, Hoejberg L, Bastholt L, Godballe C, Oturai P, Feldt-Rasmussen U. Mathiesen JS, et al. Semin Cancer Biol. 2022 Feb;79:163-179. doi: 10.1016/j.semcancer.2021.03.035. Epub 2021 Apr 1. Semin Cancer Biol. 2022. PMID: 33812987 Review.
Multiple endocrine neoplasias are rare hereditary syndromes some of them with malignant potential. Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant hereditary cancer syndrome due to germline variants in the REar …
Multiple endocrine neoplasias are rare hereditary syndromes some of them with malignant potential. Multiple endocrin …
Update on multiple endocrine neoplasia Type 1 and 2.
Al-Salameh A, Baudry C, Cohen R. Al-Salameh A, et al. Presse Med. 2018 Sep;47(9):722-731. doi: 10.1016/j.lpm.2018.03.005. Epub 2018 Jun 13. Presse Med. 2018. PMID: 29909163 Review.
Multiple endocrine neoplasia type 1 is a rare genetic syndrome, characterized by the co-occurrence, in the same individual or in related individuals of the same family, of hyperparathyroidism, duodenopancraetic neuroendocrine tumors, pituitary adenomas …
Multiple endocrine neoplasia type 1 is a rare genetic syndrome, characterized by the co-occurrence, in the same …
Genetics of Multiple Endocrine Neoplasia Type 1/Multiple Endocrine Neoplasia Type 2 Syndromes.
Hyde SM, Cote GJ, Grubbs EG. Hyde SM, et al. Endocrinol Metab Clin North Am. 2017 Jun;46(2):491-502. doi: 10.1016/j.ecl.2017.01.011. Epub 2017 Mar 18. Endocrinol Metab Clin North Am. 2017. PMID: 28476233 Review.
Multiple endocrine neoplasia syndromes types 1 and 2 represent well-characterized yet clinically heterogeneous hereditary conditions for which diagnostic and management recommendations exist; genetic testing for these inherited endocrinopathies is included in …
Multiple endocrine neoplasia syndromes types 1 and 2 represent well-characterized yet clinically heterogeneous heredita …
Multiple endocrine neoplasia type 2: an overview.
Moline J, Eng C. Moline J, et al. Genet Med. 2011 Sep;13(9):755-64. doi: 10.1097/GIM.0b013e318216cc6d. Genet Med. 2011. PMID: 21552134 Free article. Review.
Multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and multiple endocrine neoplasia type 2B are collectively associated with a 70-100% risk of medullary thyroid carcinoma by age 70 years. Pheo …
Multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and multiple endocr …
Non-mammalian models of multiple endocrine neoplasia type 2.
Das TK, Cagan RL. Das TK, et al. Endocr Relat Cancer. 2018 Feb;25(2):T91-T104. doi: 10.1530/ERC-17-0411. Endocr Relat Cancer. 2018. PMID: 29348307 Free PMC article. Review.
Twenty-five years ago, RET was identified as the primary driver of multiple endocrine neoplasia type 2 (MEN2) syndrome. MEN2 is characterized by several transformation events including pheochromocytoma, parathyroid adenoma and, especially penetr …
Twenty-five years ago, RET was identified as the primary driver of multiple endocrine neoplasia type 2 (M …
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results.
Machens A, Dralle H. Machens A, et al. Curr Opin Oncol. 2024 Jan 1;36(1):1-12. doi: 10.1097/CCO.0000000000001009. Epub 2023 Nov 3. Curr Opin Oncol. 2024. PMID: 37975407 Review.
PURPOSE OF REVIEW: Significant advances have transformed our understanding of the molecular biology and natural history of multiple endocrine neoplasia type 2 (MEN2). This progress enacted a paradigm shift with regard to routine neck dissection …
PURPOSE OF REVIEW: Significant advances have transformed our understanding of the molecular biology and natural history of multiple …
Multiple endocrine neoplasia type 2.
Wohllk N, Schweizer H, Erlic Z, Schmid KW, Walz MK, Raue F, Neumann HP. Wohllk N, et al. Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):371-87. doi: 10.1016/j.beem.2010.02.001. Best Pract Res Clin Endocrinol Metab. 2010. PMID: 20833330 Review.
Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant cancer syndrome with major components of medullary thyroid carcinoma (MTC), pheochromocytoma and hyperparathyroidism. The disease is caused by germline mutations of the RET pro …
Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant cancer syndrome with major component …
Pheochromocytomas in Multiple Endocrine Neoplasia Type 2.
Tsang VH, Tacon LJ, Learoyd DL, Robinson BG. Tsang VH, et al. Recent Results Cancer Res. 2015;204:157-78. doi: 10.1007/978-3-319-22542-5_7. Recent Results Cancer Res. 2015. PMID: 26494388 Review.
Over 30% of PCs are associated with germline mutations, including re-arranged in transfection (RET) mutations seen in multiple endocrine neoplasia type 2 (MEN2) syndromes. Around 40% of individuals with MEN2 develop PC, though it is rarely the p …
Over 30% of PCs are associated with germline mutations, including re-arranged in transfection (RET) mutations seen in multiple end …
Multiple endocrine neoplasia type 2.
Gertner ME, Kebebew E. Gertner ME, et al. Curr Treat Options Oncol. 2004 Aug;5(4):315-25. doi: 10.1007/s11864-004-0022-6. Curr Treat Options Oncol. 2004. PMID: 15233908 Review.
Multiple endocrine neoplasia type 2 (MEN-2) is a hereditary syndrome that is transmitted in an autosomal dominant pattern. MEN-2A, MEN-2B, and familial medullary thyroid cancer (MTC) comprise the MEN-2 syndrome. ...
Multiple endocrine neoplasia type 2 (MEN-2) is a hereditary syndrome that is transmitted in an autosomal …
Advances in risk-oriented surgery for multiple endocrine neoplasia type 2.
Machens A, Dralle H. Machens A, et al. Endocr Relat Cancer. 2018 Feb;25(2):T41-T52. doi: 10.1530/ERC-17-0202. Epub 2017 Sep 7. Endocr Relat Cancer. 2018. PMID: 28883084 Review.
This is why more penetrant mutations were overrepresented in early multiple endocrine neoplasia type 2 (MEN2) studies, whereas less penetrant mutations went underrepresented. ...
This is why more penetrant mutations were overrepresented in early multiple endocrine neoplasia type 2 (M …
2,354 results